Company Quick10K Filing
American Lorain
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-12
10-Q 2019-03-31 Filed 2019-05-14
10-K 2018-12-31 Filed 2019-04-15
10-Q 2018-09-30 Filed 2018-11-19
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-21
10-K 2017-12-31 Filed 2018-04-17
10-Q 2017-09-30 Filed 2017-12-11
10-Q 2017-06-30 Filed 2017-12-11
10-Q 2017-03-31 Filed 2017-12-11
10-K 2016-12-31 Filed 2017-10-31
10-Q 2016-09-30 Filed 2016-11-21
10-Q 2016-06-30 Filed 2016-08-22
10-Q 2016-03-31 Filed 2016-05-23
10-K 2015-12-31 Filed 2016-04-14
10-Q 2015-09-30 Filed 2015-11-20
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-15
10-K 2014-12-31 Filed 2015-04-15
10-Q 2014-09-30 Filed 2014-11-19
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-15
10-K 2013-12-31 Filed 2014-03-31
10-Q 2013-09-30 Filed 2013-11-14
10-Q 2013-06-30 Filed 2013-08-14
10-Q 2013-03-31 Filed 2013-05-15
10-Q 2012-09-30 Filed 2012-11-14
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-15
10-K 2011-12-31 Filed 2012-03-30
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-16
10-K 2010-12-31 Filed 2011-03-31
10-Q 2010-09-30 Filed 2010-11-15
10-Q 2010-06-30 Filed 2010-08-11
10-Q 2010-03-31 Filed 2010-05-13
10-K 2009-12-31 Filed 2010-03-29
8-K 2020-03-19
8-K 2020-02-28
8-K 2020-02-10
8-K 2019-10-25
8-K 2019-09-10
8-K 2019-07-01
8-K 2019-06-24
8-K 2019-06-17
8-K 2019-05-09
8-K 2019-04-26
8-K 2019-04-24
8-K 2018-10-17
8-K 2018-10-02
8-K 2018-09-26
8-K 2018-09-04
8-K 2018-07-13
8-K 2018-05-23
8-K 2018-04-30
8-K 2018-04-24
8-K 2018-04-18
8-K 2018-01-05

American Lorain Financials

ALN Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
11 Good Energy (ELVN)
Supernova Partners Acquisition Co III, Ltd. (STRE-WT)
1347 Capital Corp (TFSC)
Ameri Metro, Inc. (formerly Yellowwood) (ARMT)
Gores Technology Partners, Inc. (GTPAW)
Bioquest Corp (BQST)
BriaCell Therapeutics Corp. (BCTXW)
Ameren Illinois Co (AILNP)
DD3 Acquisition Corp. II (DDMXW)
8i Acquisition 2 Corp. (LAX)
Acumen Pharmaceuticals, Inc. (ABOS)
Aerovate Therapeutics, Inc. (AVTE)
Frontier Investment Corp (FICV)
Gobi Acquisition Corp. (GOBI)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
HEALTH REVENUE ASSURANCE HOLDINGS, INC. (HRAA)
Ocean Biomedical, Inc. (OCEA)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Cash9,60611,44017,35319,49819,56916,73132,34631,86934,38833,16133,85742,71942,21640,78830,28036,74737,26731,14520,66430,44638,52437,44197180383083285300385437
Accounts Receivable27,00335,10641,47032,10333,44552,66748,73437,69032,76145,47254,07137,95831,78145,14958,80636,07033,86541,14362,53234,80130,33642,6233,2531,3411,3711,6777301,2141,2551,523
Inventory41,09834,83034,34935,90040,03551,95038,07347,74549,70853,86641,95053,12062,16777,46551,64864,62763,11458,00343,71250,57153,86045,76511,84120,22923,59623,06010,59310,46110,5006,449
PP&E73,77274,81984,37784,11183,33585,19584,64084,27787,55887,57187,56186,91686,13590,19189,14988,36187,81684,82482,11078,19975,05173,88351,89753,85054,13554,77253,69625,82424,53213,116
Assets181,929188,897218,698217,168216,641247,853250,365252,156262,563279,765303,046310,148318,061360,977336,542329,097333,434325,990309,538286,866281,090285,531148,253142,816144,702141,41768,48872,76869,78435,369
Accounts Payable4,0924,9613,9003,9973,3403,3633,6472,4112,3452,6534,0163,3894,20720,09910,07112,28714,88018,68022,4646,8216,7147,9025,5145,0504,8714,0114,1511,0371,4441,899
Long-Term Debt15,38715,56616,92216,99118,04534,38751,53751,13851,35255,29651,80754,23254,30545,93531,74130,74230,00329,90828,948
Liabilities43,18340,47961,75055,80851,23176,82369,66368,05773,09084,63699,938107,617113,073152,117126,775120,902121,039117,780107,56974,84475,58880,29382,15779,27982,78878,64310,156
Stockholders' Equity138,746148,418156,949161,360165,410171,029180,702184,099189,473195,129203,109202,531204,988208,860209,766208,195212,395208,2101,96866,096-3,046-10,020-8,85925,214
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Revenue35,72755,64291,40437,14140,81757,973103,74334,81034,06553,10493,30131,68932,51655,26498,08437,55735,54847,68294,52931,71932,01040,815-24,8771,9061,2788761,0501,018636744
Cost of Revenue28,07043,29173,17229,68332,31645,58380,98327,41327,03442,78774,87425,58424,89146,10883,00931,94029,74239,39278,12425,82826,09034,487-17,2401,6611,5672521,98490171574
Gross Profit7,65712,35118,2317,4588,50112,38922,7607,3977,03110,31718,4276,1057,6259,15715,0755,6185,8068,29016,4055,8915,9206,327-7,636245-289623-934116565170
R&D
SG&A2,6824,1507,4272,6732,8753,9389,7623,2133,0493,5927,8843,1642,9686,4079,7574,7365,6084,2247,4973,2112,6062,31538,7928,7002622,26733,993184609752
Tax1,8161,8881,9092,6041,4072,0382,0973,1251,0553,1842,2857509629627117888089682,2612,100815823-3713060157253000
Net Income3,4707,8927,1553,7593,5625,6088,8152,6142,5774,4878,0111,7452,237730-306-1,071-1,4011,878-598-2,943143556-134,117-15,769-2,0304,304-64,811-58-71146,840
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Cash Operating-5,4291,155-1,6239,2932,659-25,07622,080-1,3642,180-12,6013,3397,019-3,541-2,88810,79516,2833,3966,2918,484-12,3332,103-3,040-16,5167,60414,599-9,627-1,475-5,535-1,417
Cash Investing-3,6273,572-14,163-2,707659-1,946647-1,874-4,769837-15,163-3,708-1,897-13,3477,789-4,326-2,384-6,3906,0793,1949,5781,874-5,732-7,615-13,85210,103-3-2-5,422
Cash Financing-1,910-4,51020,500-4,361-3,73224,502-8,0841,9784,45310,00512,5517,8734,71612,029-28,269-5,629-614-6,209-19,1605,923-2,468-2,2171,79802,380-435-4821,2751,28711,366